Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy... Show more
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VVOAX | 20.75 | N/A | N/A |
Invesco Value Opportunities A | |||
TEOIX | 9.07 | -0.01 | -0.11% |
Transamerica Emerging Markets Eq I | |||
THOCX | 38.75 | -0.14 | -0.36% |
Thornburg Global Opportunities C | |||
RYAZX | 179.24 | -1.44 | -0.80% |
Rydex S&P SmallCap 600 Pure Value H | |||
MNHCX | 25.05 | -0.24 | -0.95% |
Manning & Napier Pro-Blend Max Term L |
A.I.dvisor tells us that NBTX and PBYI have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NBTX and PBYI's prices will move in lockstep.
Ticker / NAME | Correlation To NBTX | 1D Price Change % | ||
---|---|---|---|---|
NBTX | 100% | N/A | ||
PBYI - NBTX | 28% Poorly correlated | -0.46% | ||
GLMD - NBTX | 26% Poorly correlated | +1.46% | ||
CRMD - NBTX | 25% Poorly correlated | +0.57% | ||
IVF - NBTX | 24% Poorly correlated | -5.62% | ||
GLPG - NBTX | 24% Poorly correlated | -0.17% | ||
More |